Details for 2021166413

Up to date per 01.04.2026

Actions

Title / Product Name

VERWENDUNG VON CANNABIDIOL BEI DER BEHANDLUNG VON EPILEPTISCHEN ANFÄLLEN BEI DOOSE-SYNDROME

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021166413

EP Publication Number

3888641

E-Number

1835151

Language

PCT Number

Publication Date

06.10.2021 A

10.09.2025 B1

Registration Date

10.09.2025

AT Publication Date

15.09.2025

Application Date

14.10.2015

Registration Number

Priorities

14.10.2014

201418169

IPC

A61K 31/05 20060101AFI20210802BHEP

Maximum Duration of Protection

14.10.2035

Owner

Jazz Pharmaceuticals Research UK Limited Building 730 Kent Science Park Sittingbourne Kent ME9 8AGGB

Representative

No representatives present

Inventor

GUY, Geoffrey Sittingbourne, Kent ME9 8AGGB

WRIGHT, Stephen Sittingbourne, Kent ME9 8AGGB

MEAD, Alice Sittingbourne, Kent ME9 8AGGB

DEVINSKY, OrrinDepartment of Neurology NYU Comprehensive Epilepsy Center 223 East 34th Street New York, NY New York 10016US

Information about Fees